By Dietrich Knauth NEW YORK, June 17 (Reuters) - A federal judge sent Bayer's proposed $7.25 billion Roundup settlement back ...
Bayer AG won a legal fight that brings the company a step closer to getting Missouri state court approval for a proposed ...
Medical Device Network on MSN
FDA approves Bayer’s Ambelvist contrast agent
The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.
Bayer AG shares are facing a make-or-break few weeks, with two upcoming court developments key to stemming a more than $60 ...
Beijing, June 11, 2026 - On this day, Bayer and Peking University (PKU) signed the fifth strategic collaboration agreement.
Cancer victims argue the proposed $7.25 billion Roundup "sweetheart deal" benefits Bayer and lawyers more than those harmed by the herbicide.
Bayer has acquired Perfuse Therapeutics, including the full rights to the PER-001 intravitreal implant, which is in ...
Following its 2018 acquisition of Monsanto, Bayer has spent years defending tens of thousands of lawsuits alleging that ...
Bayer has no plans to spin off Monsanto, a representative said on Tuesday, even as the company faces an avalanche of ...
Latham Quality, a north Iowa seed company, alleges in a lawsuit that Bayer has used anticompetitive practices to corner the GMO corn seed business.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results